Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Solventum Corporation before investing.

In this article, we go over a few key elements for understanding Solventum Corporation’s stock price such as:

• Solventum Corporation’s current stock price and volume
• Why Solventum Corporation’s stock price changed recently
• Upgrades and downgrades for SOLV from analysts
• SOLV’s stock price momentum as measured by its relative strength

About Solventum Corporation (SOLV)

Before we jump into Solventum Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Want to learn more about Solventum Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Solventum Corporation.

Solventum Corporation’s Stock Price as of Market Close

As of July 31, 2026, 1:00 PM, CST, Solventum Corporation’s stock price was $85.565.

Solventum Corporation is down 1.45% from its previous closing price of $86.820.

During the last market session, Solventum Corporation’s stock traded between $84.720 and $86.390. Currently, there are approximately 174.20 million shares outstanding for Solventum Corporation.

Solventum Corporation’s price-earnings (P/E) ratio is currently at 10.6, which is low compared to the Health Care Equipment & Supplies industry median of 30.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Solventum Corporation Stock Price History

Solventum Corporation’s (SOLV) price is currently up 10.91% so far this month.

During the month of July, Solventum Corporation’s stock price has reached a high of $88.650 and a low of $74.760.

Over the last year, Solventum Corporation has hit prices as high as $88.650 and as low as $62.380. Year to date, Solventum Corporation’s stock is up 7.98%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Solventum Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there were 0 analysts who downgraded Solventum Corporation’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Solventum Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Solventum Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Solventum Corporation’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Solventum Corporation (SOLV) by visiting AAII Stock Evaluator.

Relative Price Strength of Solventum Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Solventum Corporation has a weighted four-quarter relative price strength of 6.27%, which translates to a Momentum Score of 73 and is considered to be Strong.

Want to learn more about how Solventum Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Solventum Corporation Stock Price: Bottom Line

As of July 31, 2026, Solventum Corporation’s stock price is $85.565, which is down 1.45% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Solventum Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.